
==== Front
Rom J Morphol Embryol
Rom J Morphol Embryol
RJME
Romanian Journal of Morphology and Embryology
1220-0522
2066-8279
Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest

39020538
650224243250
10.47162/RJME.65.2.10
Original Paper
Automated cutaneous squamous cell carcinoma grading using deep learning with transfer learning
Buruiană Alexandra 1
Şerbănescu Mircea-Sebastian 23
Pop Bogdan 1
Gheban Bogdan-Alexandru 45
Georgiu Carmen 15
Crişan Doiniţa 15
Crişan Maria 46
1 Department of Pathology, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
2 Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, Romania
3 Department of Pathology, Philanthropy Municipal Clinical Hospital, Craiova, Romania
4 Department of Histology, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
5 Department of Pathology, Emergency Clinical County Hospital, Cluj-Napoca, Romania
6 Clinic of Dermatology, Emergency Clinical County Hospital, Cluj-Napoca, Romania
Corresponding Author: Mircea-Sebastian Şerbănescu, Associate Professor, MD, PhD Department of Medical Informatics and Biostatistics University of Medicine and Pharmacy of Craiova 2 Petru Rareş Street 200349 Craiova Romania + 40745–766 610 mircea_serbanescu@yahoo.com
Apr-Jun 2024
30 6 2024
65 2 243250
05 4 2024
30 6 2024
Copyright © 2024, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
2024
https://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
Introduction: Histological grading of cutaneous squamous cell carcinoma (cSCC) is crucial for prognosis and treatment decisions, but manual grading is subjective and time-consuming. Aim: This study aimed to develop and validate a deep learning (DL)-based model for automated cSCC grading, potentially improving diagnostic accuracy (ACC) and efficiency. Materials and Methods: Three deep neural networks (DNNs) with different architectures (AlexNet, GoogLeNet, ResNet-18) were trained using transfer learning on a dataset of 300 histopathological images of cSCC. The models were evaluated on their ACC, sensitivity (SN), specificity (SP), and area under the curve (AUC). Clinical validation was performed on 60 images, comparing the DNNs’ predictions with those of a panel of pathologists. Results: The models achieved high performance metrics (ACC>85%, SN>85%, SP>92%, AUC>97%) demonstrating their potential for objective and efficient cSCC grading. The high agreement between the DNNs and pathologists, as well as among different network architectures, further supports the reliability and ACC of the DL models. The top-performing models are publicly available, facilitating further research and potential clinical implementation. Conclusions: This study highlights the promising role of DL in enhancing cSCC diagnosis, ultimately improving patient care.

cutaneous squamous cell carcinoma
deep learning
histological grading
transfer learning
artificial intelligence
==== Body
pmcIntroduction

Cutaneous squamous cell carcinoma (cSCC), a prevalent skin cancer originating from the outer skin layer, arises from abnormal cell growth (dysplasia) that progresses to invasive cancer [1, 2]. It commonly affects sun-exposed areas, with a predilection for the head and neck [2, 3]. Incidence rates are increasing globally, particularly in Western countries, with higher rates observed in older individuals and men [4, 5, 6, 7, 8].

While generally less aggressive than melanoma, cSCC can be lethal, especially if diagnosed late or with certain high-risk subtypes [9, 10]. The global rise in cSCC cases underscores the need for comprehensive public health strategies, including prevention, early detection, and effective treatment [5, 8].

Histological grading, based on the degree of cellular differentiation, is crucial for prognosis and treatment decisions [2, 11]. It guides interventions, ranging from surgical excision for low-grade tumors to Mohs surgery, radiation therapy, or systemic treatments like Cemiplimab for high-grade or advanced cases [12, 13]. Furthermore, histological grading aids in identifying high-risk patients who require closer monitoring and facilitates research into the molecular underpinnings of cSCC progression [13, 14, 15].

Artificial intelligence (AI), as part of machine learning (ML) and deep learning (DL) in particular, is transforming histopathology by enhancing diagnostic accuracy (ACC), prognostication, and disease management [16, 17, 18]. ML algorithms, trained on digitized tissue slides, can identify patterns indicative of specific pathologies, augmenting pathologists’ capabilities and potentially leading to faster, more precise diagnoses [19, 20, 21].

DL, especially convolutional neural networks (CNNs), has emerged as a powerful tool for histopathology image analysis, facilitating tasks like tissue classification, tumor detection, and biomarker identification [22, 23, 24]. Moreover, AI models can predict disease progression and treatment responses, enabling personalized medicine approaches [18, 25].

Transfer learning (TL), a technique where a pre-trained model is adapted to a new task, is particularly valuable in histopathology due to the limited availability of annotated data [26]. By leveraging knowledge from models trained on large, general datasets like ImageNet, TL significantly reduces the need for extensive training data and accelerates model development while often enhancing performance on specific histopathology tasks [22, 27].

As shown above, histological grading of cSCC serves as a critical prognostic indicator, significantly influencing therapeutic decision-making and risk stratification, which are essential for optimal clinical management [10, 11, 12, 13, 28]. However, the current reliance on manual grading introduces inherent subjectivity, leading to possible interobserver variability due to differences in pathologists’ experience, training, and potential fatigue. Furthermore, manual grading is time-consuming, particularly with complex specimens, and suffers from limited reproducibility due to the potential for subjective interpretation of grading criteria. Additionally, the process necessitates trained pathologists, a resource that may be scarce in certain settings.

Aim

Given the inherent limitations of manual grading in cSCC, the aim of this study was to develop and validate a DL-based model for automated cSCC grading that can objectively and consistently classify cSCC in three grading classes (G1, G2, and G3), potentially reducing interobserver variability, improving diagnostic efficiency and time, and ultimately enhancing patient care.

Materials and Methods

Materials

Forty-seven consecutive cases of cSCC, obtained with approval from the Research Ethics Committees of the Emergency Clinical County Hospital, Cluj-Napoca, Romania (Approval No. 38789/13.09.2021) and the Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca (AVZ2/8.11.2021), were included in this study. Following standard histological processing and Hematoxylin–Eosin (HE) staining, the excised tissue sections were scanned using a Pannoramic SCAN II slide scanner (3DHISTECH, Budapest, Hungary) with a ×40 objective. From each whole-slide image (WSI), 1000×1000 pixel crops in a 24-bit red, green, and blue (RGB) color space were extracted by a trained pathologist. A panel of three pathologists independently reviewed these crops, and only those with unanimous diagnostic agreement were retained for subsequent analysis.

For each of the three grades (G1, G2, and G3), 100 images were selected. Samples of the selected images for each grade are presented in Figure 1.

Figure 1 Dataset sample. The first row resembles images labeled as G1, the second row as G2, and the third row as G3. Hematoxylin–Eosin (HE) staining, ×200

Methods

We trained three distinct classification deep neural networks (DNNs) with diverse architectures, originally designed for classifying real-world images into 1000 categories from the ImageNet dataset [29]. Utilizing the concept of TL [30], we adapted these networks to classify SCC images into three grading scores: G1, G2, and G3. The networks underwent modification, re-training, and thorough statistical evaluation. The top-performing network from each architecture were tested on 60 new images, with results compared to assessments by a panel of three pathologists. All computational tasks were conducted using MATLAB® (MathWorks, USA).

The three DNNs were selected based on previous research [31, 32] and their balance between ACC and prediction time [33]. The first network, AlexNet [34], is a CNN comprising five convolutional layers interspersed with max-pooling layers, followed by two fully connected layers, and concluding with a 1000-class Softmax layer. This model, introduced in 2012, can be freely downloaded [35] and is available in MATLAB. The second model, GoogLeNet [36], features a 22-layer architecture with the innovative “inception” modules, significantly different from AlexNet. Released in 2014, this model is also freely available [37] and accessible in MATLAB. The third model, ResNet-18 [38], incorporates a non-linear, 18-layer architecture known for its residual learning approach, introduced in 2016. This model is likewise available in MATLAB.

For each model, the final classification layers were replaced to adapt to the new task of classifying SCC images into three grading classes. Specifically, the last fully connected layer and the output layer were substituted to align with our dataset’s labels.

The modified networks were re-trained on the new dataset, with 10% of images reserved for validation and 90% used for training, employing a 10-fold cross-validation method. Training hyperparameters were standardized across all architectures, with a mini-batch size of 100, an initial learning rate of 0.0001, and a validation patience of four epochs. Stochastic gradient descent with momentum was utilized as the optimizer. Performance metrics included mean ACC, sensitivity (SN), specificity (SP), and area under the curve (AUC).

Clinical evaluation

A set of 60 images from six consecutive SCC cases were randomly selected from new WSIs, following the same procedure as the original dataset creation. These images were classified using the application and independently evaluated by three pathologists. Agreement between the networks and the pathologists was assessed.

Statistical assessment

Due to the stochastic nature of DNN algorithms, which are influenced by the specific training and validation datasets, we ensured robust results by running each model 100 times using 10-fold cross-validation. For each run, training and validation data were randomly selected but kept consistent across all three networks to enable direct performance comparisons. The normality of the data distribution was assessed using the Kolmogorov–Smirnov, Lilliefors, and Shapiro–Wilk tests.

The agreement between the networks and the panel of pathologists was evaluated using Cohen’s kappa (κ) coefficient [39]. The coefficient ranges between 0 and 1, with values close to 0 indicating no agreement and values close to 1 indicating perfect agreement. For interpretability and consistency, Landis & Koch [40] guidelines were used.

Results

A total of 300 trained networks resulted, 100 having AlexNet architecture, 100 having GoogLeNet architecture, and the last 100 having ResNet-18 architecture. Mean and standard deviation (SD) for ACC, SN, SP, and AUC of the networks, on the hole dataset are presented in Table 1.

Table 1 Performance assessment, mean ± SD

	AlexNet

	GoogLeNet

	ResNet-18

	ANOVA

	
ACC [%]

	85.5±5.5

	86.2±6.07

	85.5±5.6

	p >0.05

	
SN

	0.854±0.055

	0.862±0.060

	0.855±0.056

	p >0.05

	
SP

	0.927±0.027

	0.931±0.030

	0.927±0.028

	p >0.05

	
AUC

	0.983±0.016*

	0.978±0.021

	0.973±0.023*

	p <0.05

	
ACC: Accuracy; ANOVA: Analysis of variance; AUC: Area under the curve; SD: Standard deviation; SN: Sensitivity; SP: Specificity. *Student’s t-test, p<0.05

All normality tests (Kolmogorov–Smirnov, Lilliefors, and Shapiro–Wilk) indicated that the performance assessment variables did not follow a normal distribution. Nevertheless, in accordance with the central limit theorem [41], and given a sample size of 100, parametric tests were considered for comparing means.

One-way analysis of variance (ANOVA) showed that there are no significant differences between the performance parameters of the three networks, except for the AUC. Student’s t-test confirms there is a significant difference between the AUC of AlexNet and ResNet-18.

Confusion matrices on all dataset images from the best performing networks of each architecture are presented in Tables 2, 3, 4.

Table 2 AlexNet confusion matrix

Predicted class	G1

	G2

	G3

	
G1

	99

	1

	0

	
G2

	2

	97

	1

	
G3

	0

	1

	100

	
	Target class

	

Table 3 GoogLeNet confusion matrix

Predicted class	G1

	G2

	G3

	
G1

	99

	1

	0

	
G2

	4

	95

	1

	
G3

	1

	1

	98

	
	Target class

	

Table 4 ResNet-18 confusion matrix

Predicted class	G1

	G2

	G3

	
G1

	98

	2

	0

	
G2

	0

	99

	1

	
G3

	9

	1

	99

	
	Target class

	

The misclassification patterns are evident from the confusion matrices presented in Tables 2, 3, 4. These tables show that G1 was frequently misclassified as G2, and G3 was also often misclassified as G2. Conversely, G2 was misclassified as either G1 or G3. Misclassifications between G1 and G3 were very rare.

A sample of misclassified images is shown in Figure 2A, 2B, 2C, 2D, 2E. As anticipated, most G1 images were misclassified as G2. Similarly, G2 images were often incorrectly classified as G1 or G3, whereas G3 images were only misclassified as G2.

Figure 2 Misclassified images: (A) A G1 pattern misclassified as G2; (B and C) A G2 pattern misclassified as G1; (D) A G2 pattern misclassified as G3; (E) A G3 pattern misclassified as G2. HE staining, ×200

The best performing networks from each architecture were packed as MATLAB files and are offered on a public repository (https://github.com/Mircea-Sebastian-Serbanescu/Automated-Cutaneous-Squamous-Cell-Carcinoma-Grading-Using-Deep-Learning-with-Transfer-Learning.git).

All Cohen’s kappa were above 0.8 (Table 5), showing almost perfect agreement and concluding that the observed agreement is not accidental. The average agreement between the pathologists (0.8889) exceeded the average agreement between the networks (0.8722). However, both are very high. Panel pathologist P3 had the best agreement with ResNet-18 close to 1 (0.9667).

Table 5 Clinical evaluation assessment: Cohen’s kappa (κ) coefficient. P1–P3 represent the three panel pathologists. Sixty images from six different cases

	AlexNet

	GoogLeNet

	ResNet-18

	P1

	P2

	P3

	
AlexNet

		0.8833

	0.9000

	0.9000

	0.8833

	0.9000

	
GoogLeNet

			0.8333

	0.8667

	0.9167

	0.8667

	
ResNet-18

				0.9333

	0.8667

	0.9667

	
P1

					0.8667

	0.9333

	
P2

						0.8667

	

Discussions

AI has emerged as a valuable tool across various fields of medicine [42]. In radiology, AI algorithms can analyze medical images to detect and diagnose conditions like cancer and fractures with remarkable ACC [43, 44]. AI-powered tools in pathology can help identify abnormalities in tissue samples, aiding in disease diagnosis and prognosis [24]. In drug discovery, AI models have accelerated the identification of potential therapeutic targets and the development of new medications [45]. Furthermore, AI has shown promise in predicting patient outcomes and personalizing treatment plans based on individual characteristics and disease profiles [46].

The application of DL in pathology was delayed compared to other medical fields due to the necessity of digital slide scanners. These scanners were crucial for converting physical slides into digital data, which is essential for training DL models [26]. The availability of large datasets, coupled with advancements in computational power and algorithm development, finally allowed DL to emerge as a powerful tool in pathology, enabling significant progress in areas such as cancer diagnosis and prognosis [47].

Our research has demonstrated robust results in the grade scoring of cSCC through the application of TL techniques and general-purpose DNNs. The models achieved mean ACCs exceeding 0.85, SN of 0.85, SP of 0.92, and an AUC greater than 0.97. A statistical evaluation of the three networks employed in this study revealed comparable performance outcomes, except for a slight disparity in AUC between AlexNet and ResNet-18.

Furthermore, clinical evaluations showed a high degree of agreement between the network predictions and the assessments made by pathologists. There was also strong concordance among the pathologists themselves, as well as between different network architectures. These findings are consistent with the performance metrics obtained during the classification performance assessment phase, underscoring the possible reliability and ACC of the DL models in clinical applications and indicating that the grading features of cSCC are well-separated.

Analyzing the misclassified images shown in Figure 2A, 2B, 2C, 2D, 2E, we can intuitively understand the reasons behind the network’s decisions. The G1 pattern was misclassified as G2, likely due to the dense inflammatory infiltrate and potentially processing artifacts, such as the detachment of keratin pearls during sectioning. The G2 pattern was mistaken for G1, probably because no staining normalization or assessment was performed, leading to differences in staining. In hypereosinophilic slides, the network may misinterpret clusters of larger cells with pyknotic nuclei arranged in a whorl-like pattern as keratin pearls. Inflammation might also explain why the G2 pattern was misclassified as G3. Additionally, the small size of the keratin pearls could also contribute to this misinterpretation. Finally, the G3 pattern was misclassified as G2, likely because some necrosis resembled keratin formations. Furthermore, the presence of intervening stroma within the neoplastic cell sheets, particularly those containing blood vessels with brightly eosinophilic erythrocytes or sites of hemorrhage, may have contributed to the network’s misidentification of these areas as keratin pearls.

The DNNs have demonstrated strong classification capabilities across various medical imaging fields and pathologies. Our previous research has highlighted their effectiveness, including automatic segmentation of liver lesions in ultrasound (US) investigations [48] and the histological class prediction of breast tumors in mammography [31]. Achieving reliable results in the histopathological domain further underscores the potential utility of other imaging techniques, such as high-frequency US, which is an essential non-invasive tool for the pre-therapeutic assessment of basal cell carcinoma (BCC) [49].

These three network architectures – AlexNet, GoogLeNet, and ResNet-18 – have been previously utilized in the classification of BCC patterns [26]. While earlier studies reported good performance, the current approach has yielded superior results. Several factors may contribute to this improvement. Notably, the use of a balanced dataset likely enhanced the model’s performance. Additionally, the current task involved classifying images into only three categories, which may be inherently simpler. The grading task itself may also be more “clearly separable” with better inter-human agreement reinforcing this hypothesis. Comparable outcomes have been observed in automated Gleason grading of prostate cancer [32, 50], where TL from general-purpose DNNs achieved notable results. However, the performance in these studies was slightly lower compared to the current research.

Furthermore, while other malignancies often require costly investigations for reliable outcome prediction, such as immunohistochemistry predictive markers for primary colorectal cancer tumors [51], this is not the case for cSCC [2], making the current approach both efficient and safe.

The predominant application of DL in the context of cSCC research, as evidenced by existing literature, centers on the utilization of clinical and dermatoscopic imaging modalities. Studies conducted by Han et al. [52], Jain et al. [53], Bechelli & Delhommelle [54], Fraiwan & Faouri [55], Bassel et al. [56], Zia Ur Rehman et al. [57], and Hussain et al. [58] have employed different CNNs architectures and ML techniques to achieve automated diagnosis. The studies researched either the differentiation of benign from malignant skin lesions, including images of cSCC, or the classification of specific subtypes of skin malignancies, based on clinical or dermatoscopic image analysis. In addition to lesion classification, researchers such as Zhao et al. [59] have explored the use of DL models to assess the risk stratification of skin tumors, categorizing them into low-risk, high-risk, and dangerous categories.

While research utilizing DL on digital histopathology images of cSCC remains limited, Thomas et al. [60] developed an interpretable DL model for multi-class segmentation and classification of non-melanoma skin cancers from histopathology images. They used 290 slides of cSCC, and intraepidermal carcinoma, captured at 10× magnification with a resolution of 0.67 μm/pixel. The model, based on a U-Net architecture with a ResNet-50 encoder, achieved high ACC in both pixel-level segmentation (85%) and whole-image classification (93.6%). The study demonstrated the feasibility of using DL for automated skin cancer diagnosis and the potential for such models to assist pathologists in tasks like surgical margin assessment.

Wako et al. [61] developed a DL system to classify SCC margins in histopathology images. Using 3972 images for training, 492 for validation, and 84 for testing, they employed pre-trained models VGG16, ResNet-50, MobileNetV2, and EfficientNetB0, achieving 95.2% ACC [61]. This demonstrates the potential of DL to improve the ACC and efficiency of SCC margin assessment [61].

Davis et al. employed DL on 95 WSIs of frozen sections obtained from Mohs micrographic surgery for cSCC [62]. Utilizing 256×256-pixel image patches and a ResNet-101 model for tumor classification at the patch level, the algorithm achieved an AUC of 98.1%. Notably, performance was superior for poorly and moderately differentiated tumors (AUC 96.8%) compared to well-differentiated tumors (AUC 89.5%).

Ruini et al. developed a ML model using MobileNetV2 to automatically detect SCC in ex vivo confocal laser scanning microscopy (CLSM) images [63]. Trained and validated on 543 grayscale CLSM images, the model achieved a high AUC of 0.95, demonstrating the potential for faster and more accurate SCC diagnosis [633]. While promising, further validation with external datasets is needed to confirm its generalizability.

In a retrospective analysis involving 104 cSCC patients, Pérez-Baena et al. [64] developed a novel ML-derived cellular morphometric risk score (CMRS) and compared it to the Brigham and Women’s Hospital (BWH) staging system. The CMRS demonstrated independent prognostic value, but when combined with the BWH staging system, it significantly enhanced the ACC of risk stratification, especially regarding local recurrence and nodal metastasis. This approach objectively underscores the added value of ML in clinical prognostication.

Study limitations

A significant limitation of this study is the size of the dataset. Large datasets are essential for optimizing the performance of image analysis systems. Our dataset should be considered small for this specific task. Despite this, we have mitigated the issue of class imbalance, a common challenge in medical classification tasks, through the study’s design. This approach allowed us to achieve better than expected results.

Another limitation is that the data originates from a single medical center and was scanned using a single WSI scanner. More than that, the staining was not normalized [65].

Stroma and deep learning: a future direction

The tumor microenvironment (TME) plays a crucial role in cancer progression, and the stroma, a major component of the TME, has been implicated in cSCC development and metastasis [15]. The stroma consists of various cell types, including fibroblasts, immune cells, and endothelial cells, as well as extracellular matrix (ECM) components. Interactions between tumor cells and stromal cells can promote tumor growth, angiogenesis, and immune evasion [66]. The composition of the stroma, including the presence of specific immune cells and the organization of the ECM, can influence the aggressiveness of cSCC and its response to therapy [64].

DL models can be leveraged to analyze the stromal compartment of cSCC, potentially revealing novel insights into tumor–stroma interactions. For instance, DL algorithms could be trained to quantify stromal features such as fibroblast density, collagen deposition, vessel density and position and immune cell infiltration. These features could then be correlated with clinical outcomes, such as tumor aggressiveness and metastatic potential, to identify prognostic biomarkers and potential therapeutic targets.

Furthermore, DL models could be used to analyze spatial relationships between tumor cells and stromal components. This could help elucidate the mechanisms by which stromal cells promote tumor growth and metastasis, paving the way for the development of novel therapeutic strategies targeting the TME. For example, DL could be used to identify specific patterns of stromal cell infiltration that are associated with poor prognosis or resistance to therapy.

Conclusions

This paper presents an approach for cSCC grading using image classification based on TL in DL, trained on a dataset of only 300 images. DNN derived from AlexNet, GoogLeNet, and ResNet-18 were used, achieving average ACC, SN, SP, and AUC scores of approximately 0.85, 0.85, 0.93, and 0.97, respectively. For this task, all networks performed similarly, indicating that the grading features of cSCC are well-separated. In the clinical assessment, grading agreement measured through Cohen’s kappa showed that the neural networks had similar agreement levels with the pathologists and among themselves. There is also a very high agreement between pathologists on cSCC grading. The top-performing networks from each architecture have been made available in a public repository.

Conflict of interests

The authors declare that they have no conflict of interests.
==== Refs
References

1 Caudill J Thomas JE Burkhart CG The risk of metastases from squamous cell carcinoma of the skin Int J Dermatol 2023 62 4 483 486 35324009
2 WHO Classification of Tumours Editorial Board Keratinocytic/epidermal tumours Scolyer RA Skin tumours 5th 2023 Lyon, France International Agency for Research on Cancer (IARC) Press
3 Fijałkowska M Koziej M Antoszewski B Detailed head localization and incidence of skin cancers Sci Rep 2021 11 1 12391 12391 34117314
4 Tokez S Wakkee M Louwman M Noels E Nijsten T Hollestein L Assessment of cutaneous squamous cell carcinoma (cSCC) in situ incidence and the risk of developing invasive cSCC in patients with prior cSCC in situ vs the general population in the Netherlands, 1989-2017 JAMA Dermatol 2020 156 9 973 981 32609322
5 Huang S Jiang J Wong HS Zhu P Ji X Wang D Global burden and prediction study of cutaneous squamous cell carcinoma from 1990 to 2030: a systematic analysis and comparison with China J Glob Health 2024 14 04093 04093 38695259
6 Eggermont CJ Eggermont AMM Shifting landscape in skin cancer incidence: the rising tide of cutaneous squamous cell carcinoma and potential implications for prevention Br J Dermatol 2024 190 4 460 461 38099564
7 Leiter U Keim U Garbe C Epidemiology of skin cancer: update 2019 Adv Exp Med Biol 2020 1268 123 139 32918216
8 Guo A Liu X Li H Cheng W Song Y The global, regional, national burden of cutaneous squamous cell carcinoma (1990-2019) and predictions to 2035 Eur J Cancer Care 2023
9 Migden MR Rischin D Schmults CD Guminski A Hauschild A Lewis KD Chung CH Hernandez-Aya L Lim AM Chang ALS Rabinowits G Thai AA Dunn LA Hughes BGM Khushalani NI Modi B Schadendorf D Gao B Seebach F Li S Li J Mathias M Booth J Mohan K Stankevich E Babiker HM Brana I Gil-Martin M Homsi J Johnson ML Moreno V Niu J Owonikoko TK Papadopoulos KP Yancopoulos GD Lowy I Fury MG PD-1 blockade with Cemiplimab in advanced cutaneous squamous-cell carcinoma N Engl J Med 2018 379 4 341 351 29863979
10 Martorell-Calatayud A Sanmartín Jimenez Cruz Mojarrieta Guillén Barona Cutaneous squamous cell carcinoma: defining the high-risk variant Actas Dermosifiliogr 2013 104 5 367 379 23683506
11 Schmitz L Kanitakis J Histological classification of cutaneous squamous cell carcinomas with different severity J Eur Acad Dermatol Venereol 2019 33 Suppl 8 11 15 31833602
12 Maubec E Update of the management of cutaneous squamous-cell carcinoma Acta Derm Venereol 2020 100 11 adv00143 adv00143 32346744
13 García-Foncillas J Tejera-Vaquerizo A Sanmartín O Rojo F Mestre J Martín S Azinovic I Mesía R Update on management recommendations for advanced cutaneous squamous cell carcinoma Cancers (Basel) 2022 14 3 629 629 35158897
14 Feng J Zhang W Zeng W Dong X Wang Y Gu Y Lan Y Yang W Lu H Expression analysis of retinal G protein-coupled receptor and its correlation with regulation of the balance between proliferation and aberrant differentiation in cutaneous squamous cell carcinoma Acta Derm Venereol 2024 104 adv13213 adv13213 38299232
15 Fania L Didona D Di Pietro Verkhovskaia S Morese R Paolino G Donati M Ricci F Coco V Ricci F Candi E Abeni D Dellambra E Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches Biomedicines 2021 9 2 171 171 33572373
16 Ahmad Z Rahim S Zubair M Abdul-Ghafar J Artificial intelligence (AI) in medicine, current applications and future role with special emphasis on its potential and promise in pathology: present and future impact, obstacles including costs and acceptance among pathologists, practical and philosophical considerations. A comprehensive review Diagn Pathol 2021 16 1 24 24 33731170
17 Coudray N Ocampo PS Sakellaropoulos T Narula N Snuderl M Fenyö D Moreira AL Razavian N Tsirigos A Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning Nat Med 2018 24 10 1559 1567 30224757
18 Kather JN Krisam J Charoentong P Luedde T Herpel E Weis CA Gaiser T Marx A Valous NA Ferber D Jansen L Reyes-Aldasoro CC Zörnig I Jäger D Brenner H Chang-Claude J Hoffmeister M Halama N Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study PLoS Med 2019 16 1 e1002730 e1002730 30677016
19 Shafi S Parwani AV Artificial intelligence in diagnostic pathology Diagn Pathol 2023 18 1 109 109 37784122
20 Obermeyer Z Emanuel EJ Predicting the future - big data, machine learning, and clinical medicine N Engl J Med 2016 375 13 1216 1219 27682033
21 Marini N Marchesin S Otálora S Wodzinski M Caputo A van Rijthoven Aswolinskiy W Bokhorst JM Podareanu D Petters E Boytcheva S Buttafuoco G Vatrano S Fraggetta F van der Agosti M Ciompi F Silvello G Muller H Atzori M Unleashing the potential of digital pathology data by training computer-aided diagnosis models without human annotations NPJ Digit Med 2022 5 1 102 102 35869179
22 Litjens G Kooi T Bejnordi BE Setio AAA Ciompi F Ghafoorian M van der van Ginneken Sánchez CI A survey on deep learning in medical image analysis Med Image Anal 2017 42 60 88 28778026
23 Manakitsa N Maraslidis GS Moysis L Fragulis GF A review of machine learning and deep learning for object detection, semantic segmentation, and human action recognition in machine and robotic vision Technologies 2024 12 2 15 15
24 Bera K Schalper KA Rimm DL Velcheti V Madabhushi A Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology Nat Rev Clin Oncol 2019 16 11 703 715 31399699
25 Janowczyk A Madabhushi A Deep learning for digital pathology image analysis: a comprehensive tutorial with selected use cases J Pathol Inform 2016 7 29 29 27563488
26 Bungărdean RM Şerbănescu MS Streba CT Crişan M Deep learning with transfer learning in pathology. Case study: classification of basal cell carcinoma Rom J Morphol Embryol 2021 62 4 1017 1028 35673821
27 Cheplygina V de Bruijne Pluim JPW Not-so-supervised: a survey of semi-supervised, multi-instance, and transfer learning in medical image analysis Med Image Anal 2019 54 280 296 30959445
28 Kabir S Schmults CD Ruiz ES A review of cutaneous squamous cell carcinoma epidemiology, diagnosis, and management Int J Cancer Manag 2018 11 1 e60846 e60846
29 ImageNet, 2021. ImageNet [online] Available from: https://image-net.org/ 2024
30 Bozinovski S Reminder of the first paper on transfer learning in neural networks, 1976 Informatica 2020 44 3 291 302
31 Nica RE Şerbănescu MS Florescu LM Camen GC Streba CT Gheonea IA Deep learning: a promising method for histological class prediction of breast tumors in mammography J Digit Imaging 2021 34 5 1190 1198 34505960
32 erbănescu MS Manea NC Streba L Belciug S Pleşea IE Pirici I Bungărdean RM Pleşea RM Automated Gleason grading of prostate cancer using transfer learning from general-purpose deep-learning networks Rom J Morphol Embryol 2020 61 1 149 155 32747906
33 MATLAB, 2024: Pretrained deep neural networks. MATLAB & Simulink [online] Available from: https://www.mathworks.com/help/deeplearning/ug/pretrained-convolutional-neural-networks.html 2024
34 Krizhevsky A Sutskever I Hinton G ImageNet classification with deep convolutional neural networks Pereira F Advances in neural information processing systems (NIPS) 25. 26th Annual Conference on NIPS 2012 2013 New York, USA Curran Associates, Inc. 1097 1105
35 GitHub, 2021: BVLC AlexNet model [online] Available from: https://github.com/BVLC/caffe/tree/master/models/bvlc_alexnet 2024
36 Szegedy C Liu W Jia Y Reed S Anguelov D Erhan D Vanhoucke V Rabinovich A Going deeper with convolutions 2015 Institute of Electrical and Electronics Engineers (IEEE) Conference on Computer Vision and Pattern Recognition (CVPR) 2015 Jun 7-12 Boston, MA, USA
37 GitHub, 2021: BVLC GoogLeNet model [online] Available from: https://github.com/BVLC/caffe/tree/master/models/bvlc_googlenet 2024
38 He K Zhang X Ren S Sun J Deep residual learning for image recognition 2016 Institute of Electrical and Electronics Engineers (IEEE) Conference on Computer Vision and Pattern Recognition (CVPR) 2016 Jun 27-30 Las Vegas, NV, USA
39 McHugh ML Interrater reliability: the kappa statistic Biochem Med (Zagreb) 2012 22 3 276 282 23092060
40 Landis JR Koch GG The measurement of observer agreement for categorical data Biometrics 1977 33 1 159 174 843571
41 Montgomery DC Runger GC Applied statistics and probability for engineers 6th 2014 Hoboken, NJ, USA John Wiley & Sons, Inc.
42 Bekbolatova M Mayer J Ong CW Toma M Transformative potential of AI in healthcare: definitions, applications, and navigating the ethical landscape and public perspectives Healthcare (Basel) 2024 12 2 125 125 38255014
43 Bi WL Hosny A Schabath MB Giger ML Birkbak NJ Mehrtash A Allison T Arnaout O Abbosh C Dunn IF Mak RH Tamimi RM Tempany CM Swanton C Hoffmann U Schwartz LH Gillies RJ Huang RY Aerts HJWL Artificial intelligence in cancer imaging: clinical challenges and applications CA Cancer J Clin 2019 69 2 127 157 30720861
44 Hosny A Parmar C Quackenbush J Schwartz LH Aerts HJWL Artificial intelligence in radiology Nat Rev Cancer 2018 18 8 500 510 29777175
45 Paul D Sanap G Shenoy S Kalyane D Kalia K Tekade RK Artificial intelligence in drug discovery and development Drug Discov Today 2021 26 1 80 93 33099022
46 Hilton CB Milinovich A Felix C Vakharia N Crone T Donovan C Proctor A Nazha A Personalized predictions of patient outcomes during and after hospitalization using artificial intelligence NPJ Digit Med 2020 3 51 51 32285012
47 Tran KA Kondrashova O Bradley A Williams ED Pearson JV Waddell N Deep learning in cancer diagnosis, prognosis and treatment selection Genome Med 2021 13 1 152 152 34579788
48 Florescu LM Streba CT Şerbănescu MS Mămuleanu M Florescu DN Teică RV Nica RE Gheonea IA Federated learning approach with pre-trained deep learning models for COVID-19 detection from unsegmented CT images Life (Basel) 2022 12 7 958 958 35888048
49 Bungărdean RM Şerbănescu MS Colosi HA Crişan M High-frequency ultrasound: an essential non-invasive tool for the pre-therapeutic assessment of basal cell carcinoma Rom J Morphol Embryol 2021 62 2 545 551 35024743
50 erbănescu MS Oancea CN Streba CT Pleşea IE Pirici D Streba L Pleşea RM Agreement of two pre-trained deep learning neural networks built with transfer learning with six pathologists on 6000 patches of prostate cancer from Gleason2019 Challenge Rom J Morphol Embryol 2020 61 2 513 519 33544803
51 Bărbălan A Nicolaescu AC Măgăran AV Mercuţ R Bălăşoiu M Băncescu G Şerbănescu MS Lazăr OF Săftoiu A Immunohistochemistry predictive markers for primary colorectal cancer tumors: where are we and where are we going Rom J Morphol Embryol 2018 59 1 29 42 29940609
52 Han SS Kim MS Lim W Park GH Park I Chang SE Classification of the clinical images for benign and malignant cutaneous tumors using a deep learning algorithm J Invest Dermatol 2018 138 7 1529 1538 29428356
53 Jain S Singhania U Tripathy B Nasr EA Aboudaif MK Kamrani AK Deep learning-based transfer learning for classification of skin cancer Sensors (Basel) 2021 21 23 8142 8142 34884146
54 Bechelli S Delhommelle J Machine learning and deep learning algorithms for skin cancer classification from dermoscopic images Bioengineering (Basel) 2022 9 3 97 97 35324786
55 Fraiwan M Faouri E On the automatic detection and classification of skin cancer using deep transfer learning Sensors (Basel) 2022 22 13 4963 4963 35808463
56 Bassel A Abdulkareem AB Alyasseri ZAA Sani NS Mohammed HJ Automatic malignant and benign skin cancer classification using a hybrid deep learning approach Diagnostics (Basel) 2022 12 10 2472 2472 36292161
57 Zia Ur Ahmed F Alsuhibany SA Jamal SS Zulfiqar Ali Ahmad J Classification of skin cancer lesions using explainable deep learning Sensors (Basel) 2022 22 18 6915 6915 36146271
58 Hussain M Khan MA Damaševičius R Alasiry A Marzougui M Alhaisoni M Masood A SkinNet-INIO: multiclass skin lesion localization and classification using fusion-assisted deep neural networks and improved nature-inspired optimization algorithm Diagnostics (Basel) 2023 13 18 2869 2869 37761236
59 Zhao XY Wu X Li FF Li Y Huang WH Huang K He XY Fan W Wu Z Chen ML Li J Luo ZL Su J Xie B Zhao S The application of deep learning in the risk grading of skin tumors for patients using clinical images J Med Syst 2019 43 8 283 283 31300897
60 Thomas SM Lefevre JG Baxter G Hamilton NA Interpretable deep learning systems for multi-class segmentation and classification of non-melanoma skin cancer Med Image Anal 2021 68 101915 101915 33260112
61 Wako BD Dese K Ulfata RE Nigatu TA Turunbedu SK Kwa T Squamous cell carcinoma of skin cancer margin classification from digital histopathology images using deep learning Cancer Control 2022 29 10732748221132528 10732748221132528 36194624
62 Davis MJ Srinivasan G Chacko R Chen S Suvarna A Vaickus LJ Torres VC Hodge S Chen EY Preum S Samkoe KS Christensen BC LeBoeuf MR Levy JJ A deep learning algorithm to detect cutaneous squamous cell carcinoma on frozen sections in Mohs micrographic surgery: a retrospective assessment Exp Dermatol 2024 33 1 e14949 e14949 37864429
63 Ruini C Schlingmann S Jonke Ž Avci P Padrón-Laso V Neumeier F Koveshazi I Ikeliani IU Patzer K Kunrad E Kendziora B Sattler E French LE Hartmann D Machine learning based prediction of squamous cell carcinoma in ex vivo confocal laser scanning microscopy Cancers (Basel) 2021 13 21 5522 5522 34771684
64 Pérez-Baena MJ Mao JH Pérez-Losada J Santos-Briz Á Chang H Cañueto J Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma Clin Exp Dermatol 2024 49 7 692 698 37572359
65 erbănescu MS Pleşea IE A hardware approach for histological and histopathological digital image stain normalization Rom J Morphol Embryol 2015 56 2 Suppl 735 741 26429166
66 Buruiană A Gheban BA Gheban-Roşca IA Georgiu C Crişan D Crişan M The tumor stroma of squamous cell carcinoma: a complex environment that fuels cancer progression Cancers (Basel) 2024 16 9 1727 1727 38730679
